Lunsekimig
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Lunsekimig, covering 2026-02-05 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis [Phase 2]